Sandoz Group AG at JPMorgan Healthcare Conference Transcript
Good morning, and welcome to the Sandoz session of the 44th JPMorgan Healthcare Conference. My name is Sophia Graeff Buhl Nielsen. I'm an analyst here at JPMorgan on the European pharma and biotech team. And today, it's my pleasure to welcome CEO of Sandoz, Richard Saynor. (Event Instructions)
And with that, I'll hand over to Richard.
Okay. Well, thank you. Pleasure. And good morning, everybody. So I'll take you through a relatively brief presentation, talk about a bit of our history, our journey, how we're executing, and then really much more importantly, thinking about the future, as we see it over the few years and an opportunity for questions.
What I have said is we'll have a money box. Any questions on GLP-1s, we'll collect some money for disadvantaged Canadians because clearly, I'm getting a lot of questions on GLPs.
So pioneering for access for patients. So good morning. Our mission as a company is simple.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
